Latest Insights on BAC
Profit From AbbVie’s Struggles Today February 4, 2020 American Investor Today, Stocks Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
Your Coronavirus Crisis Plan: Watch for This Rally February 3, 2020 Global Economy, Investment Opportunities, Winning Investor Daily The coronavirus outbreak is setting up a huge rally for the rest of the year — and you won’t want to miss out.
What the Latest Earnings Reports Really Tell Us About Amazon, Tesla and the S&P 500 February 3, 2020 Big Picture. Big Profits., Investing, News, Stocks [15-minute video] How the latest outbreak will impact certain stocks.
2 Stock Strategies to Get Happy Rich in 2020 February 1, 2020 American Investor Today, Investment Opportunities Last week, we told you about two low-cost ways to get started on your journey to getting “happy rich” if you’re new to investing. Today, I want to profile two of our premium services. They’re a higher price point — but if you have a little extra cash, the potential reward is even higher!
No Fear Here: 4 Stocks to Beat the Wuhan Virus January 31, 2020 2020 Financial Crisis, Great Stuff Friday Four Play: The “Fear Inoculum” Edition (Did a friend forward you this email? If so, you owe them big-time! Seriously, this is Great Stuff. We don’t take that title lightly. After you’ve thanked your friend profusely, why not sign up for yourself today? It’s mostly painless. I promise.) The Wuhan coronavirus is officially a […]MEET OUR EXPERTS
Chief Strategist of Strategic Fortunes and three elite services
Founder of Weekend Trader
Research Analyst
Chief Investment Strategist of Money & Markets
Director of VIP Services
Founder of TRADEMONSTER.ai
